Spitalul Clinic Municipal Dr. Gavril Curteanu Oradea

Oradea 410469

1 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, End Stage Kidney Disease, First Line Non-Small Cell Lung Cancer

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200) — Completed